Arcutis Biotherapeutics
arcutis.com
Actively hiring
Drug Discovery
Dermatology
Health Care
As featured in
View 1 job
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Jobs
Financials
News
Arcutis Partners With Simone Biles To Raise Awareness Of Skin Conditions
Arcutis Biotherapeutics (ARQT) said Simone Biles has partnered with the company to launch the "Skin to Believe In" campaign, raising awareness of seborrheic dermatitis and eczema.
Read more
Report
Simone Biles Partners with Arcutis to Launch the Skin to Believe In Campaign, Raising Awareness of Seborrheic Dermatitis and Eczema, and Inspiring People to Explore Treatment Options
Simone Biles opens up about her experience managing the symptoms of these conditions and encourages long-term control of skin health Biles' treatment, ZORYVE (roflumilast), is the #1 prescribed branded topical therapy for three major inflammatory skin con
Read more
Report
Simone Biles Partners with Arcutis to Launch the Skin to Believe In Campaign, Raising Awareness of Seborrheic Dermatitis and Eczema, and Inspiring People to Explore Treatment ...
Read more
Report
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WESTLAKE VILLAGE, Calif., Sept. 04, 2026 (GLOBE NEWSWIRE) - Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced the grant of an aggr
Read more
Report
Arcutis Management to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
WESTLAKE VILLAGE, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) - Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that Arcutis managem
Read more
Report
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WESTLAKE VILLAGE, Calif., Aug. 07, 2026 (GLOBE NEWSWIRE) - Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced the grant of an aggre
Read more
Report
Arcutis Announces Second Quarter 2026 Financial Results and Provides Business Update
Continued strong ZORYVE (roflumilast) net product revenue growth, with Q2 revenues of $129.9 million, +59% versus Q2 of 2025, and +23% versus Q1 of 2026, driven primarily by strong demand growth Company raising 2026 full-year net product sales guidance to
Read more
Report
Arcutis Biotherapeutics (ARQT) Heads Into Earnings With Its ZORYVE Story Still Shaping Valuation
Arcutis Biotherapeutics (ARQT) is back in focus as Wall Street looks ahead to its June 2026 quarter earnings report on August 5, with expectations centered on higher earnings and revenue. See our latest analysis for Arcutis Biotherapeutics. At a recent sh
Read more
Report
Arcutis Expands Board of Directors with Appointment of Chris Peetz
WESTLAKE VILLAGE, Calif., July 16, 2026 (GLOBE NEWSWIRE) - Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovation in immuno-dermatology, today announced that Christopher "Chri
Read more
Report
Arcutis to Report Second Quarter 2026 Financial Results and Host Conference Call on August 5, 2026
WESTLAKE VILLAGE, Calif., July 15, 2026 (GLOBE NEWSWIRE) - Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that it will report i
Read more
Report
Show more news
Tech stack
Technologies named in job postings at Arcutis Biotherapeutics over the last 12 months, by layer, with the share of postings for each.
Technologies in use
3
Postings analysed
1
Stack modernity
71/100
Languages
Python
SQL
Developer tools
Microsoft Excel
Sign in to see how your skills match this stack
Sign In
Salary insights
Compensation ranges based on this company's open jobs
Median
$160k
Typical range
$155k – $280k
Open positions
8
5
Jobs
Senior
60%
Architect
40%
| Level | Jobs | Median | Typical range |
|---|---|---|---|
| Senior | 3 | $165k | $155k – $165k |
| Architect | 2 | $250k | $220k – $280k |
Highest paying role
Area Sales Director
$280k
Normalized to USD per year
All salaries at Arcutis Biotherapeutics
By role, level and city, against the market · 8 jobs with pay
Growth
Hiring Momentum
48/100
Stable
Open positions
8
0 opened / 0 closed in 30 days
ATS activity
Every ~1 days
Today
Hiring Dynamics
+100%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Sales
63% ▼
Public Policy
25% ▲
Analytics
13% ▼
Jobs
$150k – $165k per year • In office • Full-Time • 5+ years exp
Python
SQL
Microsoft Excel
Apply